Integral care program with or without palliative chemotherapy in patients with advanced cancer: multicentre randomized clinical trial. - PAI (Programa de atención Integral)

Institut de Recerca HSCSP0 个研究点开始时间: 2012年6月25日最近更新: 2013年11月18日

适应症

试验速览

暂无简介。

•1. Men and women ? 18 years of age.
•2. Patients potentially eligible to receive a new chemotherapy treatment and whose clinical condition, according to the oncologist responsible, does not identify any therapeutic strategy clearly superior to another, in the light of available scientific evidence.
•3. Patients with advanced cancers that have been treated with chemotherapy but have not submitted a complete response to treatment or who, having presented, are now in a situation of recurrence or disease progression
•5. Patients who have previously completed a number of chemotherapies. Depending on the type of cancer will be considered:
•? Cancers of the digestive and gastrointestinal
•? Head and Neck Cancers
•? Cancer Bronchopulmonary
•? Urological Cancer
•? Gynecologic Cancer
•? Central Nervous System Cancer
•6. Patients with potential capacity to complete the study, and accept and sign the informed consent.
•7. Patients whose home is located less than 10 km from the hospitals participating in the study.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 200
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 22

•1. Patients who are in course of any chemotherapy. Not be considered an exclusion criterion that the patient is enrolled in any other concomitant therapy (e.g., hormone or radiation therapy).
•2. Patients with contraindications to chemotherapy.
•3. Patients who refuse to enter into the clinical trial.

发起方

Institut de Recerca HSCSP